2024

Owrid, O. et al. (2024) “There’s no us vs. them, it’s just us”: a creative approach to centring lived experience within the AVATAR2 trial. BMC Psychiatry, (Accepted for Publication)

Eisner, E. et al. (2024) Measurement of adverse events in studies of digital health interventions for psychosis: guidance and recommendations based on a literature search and framework analysis of standard operating procedures. Schizophrenia Bulletin, (doi: 10.1093/schbul/sbae048) (PMID:38683836)

Allan, S. et al. (2024) Adverse events reporting in digital interventions evaluations for psychosis: a systematic literature search and individual level content analysis of adverse event reports. Schizophrenia Bulletin, (doi: 10.1093/schbul/sbae031) (PMID:38581410) (Early Online Publication)

2022

O'Connor, R. C. et al. (2022) SAFETEL: A pilot randomised controlled trial to assess the feasibility and acceptability of a safety planning and telephone follow-up intervention to reduce suicidal behaviour. Pilot and Feasibility Studies, 8, 156. (doi: 10.1186/s40814-022-01081-5) (PMID:35897119) (PMCID:PMC9327159)

2020

Langan-Martin, J. , Sharp, L. , Karadzhov, D. , Cleare, S. , Syrett, S., Zortea, T. and O'Connor, R. (2020) Designing a Massive Open Online Course (MOOC): Understanding Suicide and Suicide Prevention Strategies in a Global Context. Findings from the March and Sep 2019 runs. 13th Annual University of Glasgow Learning and Teaching Conference, 25 Aug 2020.

2019

Morrison, A. P. et al. (2019) Cognitive behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Health Technology Assessment, 23(7),

O'Connor, R. C. et al. (2019) SAFETEL randomised controlled feasibility trial of a safety planning intervention with follow-up telephone contact to reduce suicidal behaviour: study protocol. BMJ Open, 9(2), e025591. (doi: 10.1136/bmjopen-2018-025591) (PMID:30782938) (PMCID:PMC6377516)

2018

Morrison, A. et al. (2018) Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial. Lancet Psychiatry, 5(8), pp. 633-643. (doi: 10.1016/S2215-0366(18)30184-6) (PMID:30001930) (PMCID:PMC6063993)

Syrett, S. (2018) Why a change of diagnosis shouldn’t matter . . . but it does. British Medical Journal, 361, k1472. (doi: 10.1136/bmj.k1472) (PMID:29650508)

Articles

Owrid, O. et al. (2024) “There’s no us vs. them, it’s just us”: a creative approach to centring lived experience within the AVATAR2 trial. BMC Psychiatry, (Accepted for Publication)

Eisner, E. et al. (2024) Measurement of adverse events in studies of digital health interventions for psychosis: guidance and recommendations based on a literature search and framework analysis of standard operating procedures. Schizophrenia Bulletin, (doi: 10.1093/schbul/sbae048) (PMID:38683836)

Allan, S. et al. (2024) Adverse events reporting in digital interventions evaluations for psychosis: a systematic literature search and individual level content analysis of adverse event reports. Schizophrenia Bulletin, (doi: 10.1093/schbul/sbae031) (PMID:38581410) (Early Online Publication)

O'Connor, R. C. et al. (2022) SAFETEL: A pilot randomised controlled trial to assess the feasibility and acceptability of a safety planning and telephone follow-up intervention to reduce suicidal behaviour. Pilot and Feasibility Studies, 8, 156. (doi: 10.1186/s40814-022-01081-5) (PMID:35897119) (PMCID:PMC9327159)

Morrison, A. P. et al. (2019) Cognitive behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT. Health Technology Assessment, 23(7),

O'Connor, R. C. et al. (2019) SAFETEL randomised controlled feasibility trial of a safety planning intervention with follow-up telephone contact to reduce suicidal behaviour: study protocol. BMJ Open, 9(2), e025591. (doi: 10.1136/bmjopen-2018-025591) (PMID:30782938) (PMCID:PMC6377516)

Morrison, A. et al. (2018) Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial. Lancet Psychiatry, 5(8), pp. 633-643. (doi: 10.1016/S2215-0366(18)30184-6) (PMID:30001930) (PMCID:PMC6063993)

Syrett, S. (2018) Why a change of diagnosis shouldn’t matter . . . but it does. British Medical Journal, 361, k1472. (doi: 10.1136/bmj.k1472) (PMID:29650508)

Conference or Workshop Item

Langan-Martin, J. , Sharp, L. , Karadzhov, D. , Cleare, S. , Syrett, S., Zortea, T. and O'Connor, R. (2020) Designing a Massive Open Online Course (MOOC): Understanding Suicide and Suicide Prevention Strategies in a Global Context. Findings from the March and Sep 2019 runs. 13th Annual University of Glasgow Learning and Teaching Conference, 25 Aug 2020.